Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapy.
Saved in:
| Title: | Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapy. |
|---|---|
| Authors: | Yang, Mingli1 (AUTHOR) mingliyang@usf.edu, Schell, Michael J.2 (AUTHOR), Salk, Jesse J.3 (AUTHOR), Higgins, Jake3 (AUTHOR), Hipp, Michael3 (AUTHOR), Pflieger, Lance4 (AUTHOR), Pledger, Warren Jack5,6 (AUTHOR), Yeatman, Timothy J.1,5,6 (AUTHOR) tyeatman@usf.edu |
| Source: | Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-19. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
